The Impact of NASH to Liver Transplantations With Hepatocellular Carcinoma in the United States.

Zobair M Younossi,Michael Harring,Youssef Younossi,Janus P Ong,Saleh A Alqahtani,Maria Stepanova

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association（2021）

Cited 5|Views8

No score

Abstract

Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease worldwide.1,2 It is believed that about one fourth of the world population may have NAFLD.3 The Global Burden of Disease data suggest that NAFLD and nonalcoholic steatohepatitis (NASH) are the main drivers of liver disease burden in most regions of the world, including that of hepatocellular carcinoma (HCC).4,5.

Translated text

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined